"The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines," Jesse Goodman, acting chief scientist at the FDA, said in a prepared statement.
Given the initially limited availability of the vaccine, the government still recommends that those who are most likely to have complications from the flu, including children and pregnant women, should be the first in line for the shots.
At least one million people in the U.S. have likely been infected with the virus since April, according to the Centers for Disease Control (CDC), and 593 people have died, including about 40 children. The seasonal flu infects from 5 to 20 percent of the U.S. population every year and kills about 36,000, according to the CDC. Unlike the seasonal flu, the H1N1 swine flu virus has been found to be contagious for about a week after symptoms have receded. Researchers are recommending people with the flu stay home for several days even after they start feeling better.
Buy Cheap Levitra